16 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

SIEMENS MEDICAL INFORMATION BUS (MIB) PROTOCOL CONVERTER

FDA 510(k)
FDA Class 2 ·Cardiovascular

AtoN Optic Only

FDA UDI
LONG ISLAND TECH·00851610007114·Light, Surgical, Endoscopic, Accessory

Alpha-Tec Systems

FDA UDI
Alpha-TEC Systems, Inc.·00816085020549·Nocardia Stain Control Slides

GEN4 DIGITAL

FDA UDI
CURBELL MEDICAL PRODUCTS, INC.·00840828188890·GEN4 DIGITAL

GEN4 INTERACTIVE

FDA UDI
CURBELL MEDICAL PRODUCTS, INC.·00840828158237·GEN4 INTERACTIVE

MULTI-PULSE 2000

FDA 510(k)
FDA Class 2 ·Dental

CARTO EP NAVIGATION SYSTEM

FDA 510(k)
FDA Class 2 ·Cardiovascular

OT ULTRALINK METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·March 14, 2013

PINNACLE HIP

FDA Adverse Event
Injury ·DEPUY·Product code KWA·February 18, 2011

LIFEPAK 12 DEFIBRILLATOR/MONITOR SERIES

FDA Adverse Event
Malfunction ·PHYSIO-CONTROL, INC.·Product code MKJ·February 21, 2008

BD PLASTIPAK CONCENTRIC LUER LOCK SYRINGE

FDA Adverse Event
Malfunction ·BECTON DICKINSON, S.A.·Product code FMF·July 14, 2020

KYPHON KURVE BONE FILLER DEVICE 13GA

FDA Adverse Event
Malfunction ·MEDTRONIC MEXICO·Product code KIH·July 14, 2020

VERCISE GENUS?

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC NEUROMODULATION CORPORATION·Product code MHY·July 18, 2025

smiths medical portex Venn Reusable Tracheal Tube Introducer, 15Ch x 60cm, REF 14-504-17 and REF 14-504-17JP

FDA Enforcement
Class II ·Ongoing·Smiths Medical ASD, Inc.·December 4, 2024

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024